Table 1.
Detailed Counts of Included and Excluded Intravitreal Injections (IVI) and Study Patients of the 2019 and 2020 Cohorts
| Study Period | Patients | Eyes |
|---|---|---|
| 2020 Total | 175 | 219 |
| Excluded | 31 | 36 |
| Second encounter | 16 | 20 |
| >12 months since last visit | 6 | 6 |
| <3 injection visits | 9 | 10 |
| Study Group 2020 | 144 | 183 |
| Delayed | 46 | 62 |
| Not Delayed | 98 | 121 |
| 2019 Total | 200 | 243 |
| Excluded | 46 | 50 |
| Second encounter | 16 | 19 |
| >12 months since last visit | 17 | 17 |
| <3 injection visits | 13 | 14 |
| Control Group 2019 | 154 | 193 |
| Delayed | 23 | 26 |
| Not Delayed | 131 | 167 |